Contributed equally as first authors.
Translational and Clinical Research
Dedifferentiation-Reprogrammed Mesenchymal Stem Cells with Improved Therapeutic Potential†‡§
Article first published online: 16 NOV 2011
DOI: 10.1002/stem.764
Copyright © 2011 AlphaMed Press
Additional Information
How to Cite
Liu, Y., Jiang, X., Zhang, X., Chen, R., Sun, T., Fok, K. L., Dong, J., Tsang, L. L., Yi, S., Ruan, Y., Guo, J., Yu, M. K., Tian, Y., Chung, Y. W., Yang, M., Xu, W., Chung, C. M., Li, T. and Chan, H. C. (2011), Dedifferentiation-Reprogrammed Mesenchymal Stem Cells with Improved Therapeutic Potential. STEM CELLS, 29: 2077–2089. doi: 10.1002/stem.764
- †
Author contributions: Y.L. and X.Z.: collection and/or assembly of data, data analysis and interpretation, manuscript writing, and final approval of manuscript; X.J.: design, collection and/or assembly of data, data analysis and interpretation, manuscript writing, and final approval of manuscript; R.C., T.S., K.L.F., J.D., L.L.T., S.Y., Y.R., J.G., M.K.Y., Y.T., and W.X.: collection and/or assembly of data, data analysis and interpretation, and final approval of manuscript; Y.W.C.: collection and/or assembly of data, data analysis and interpretation, administrative support, and final approval of manuscript; M.Y.: data analysis and interpretation, provision of study material, and final approval of manuscript; C.M.C.: collection and/or assembly of data and data analysis and interpretation, T.L.: conception and design, financial support, provision of study material, data analysis and interpretation, and final approval of manuscript; H.C.C: conception and design, financial support, provision of study material, data analysis and interpretation, manuscript writing, and final approval of manuscript.
- ‡
Disclosure of potential conflicts of interest is found at the end of this article.
- §
First published online in STEM CELLSEXPRESS November 3, 2011.
- ¶
Contributed equally as first authors.
- ‖
Telephone: 8623-63628660; Fax: 8623-63626904
- ‡‡
Telephone: 852-26961105; Fax: 852-26037155
- ††
Contributed equally as corresponding authors.
Publication History
- Issue published online: 16 NOV 2011
- Article first published online: 16 NOV 2011
- Accepted manuscript online: 3 NOV 2011 08:50AM EST
- Manuscript Accepted: 27 SEP 2011
- Manuscript Received: 25 JAN 2011
Funded by
- Focused Investment Scheme and Li Ka Shing Institute of Health Sciences of the Chinese University of Hong Kong
- Morningside Foundation
- National Natural Science Foundation of China (. Grant Numbers: 30830106, 30872670, 81100475
- National Basic Research Program of China. Grant Number: 012CB944900
- Fundamental Research Funds for the Central Universities (Jinan University)
- Chinese University of Hong Kong. Grant Numbers: 2009.1.071, 2010.1.016
- Hong Kong University Grants Committee. Grant Numbers: GRF2010/2011, CUHK466710
- NSFC grant. Grant Number: 31140034
Cited in:
- CrossRef
This article has been cited by:
- 1, , , The Potential for Cell-Based Therapy in Perinatal Brain Injuries, Translational Stroke Research, 2013, 4, 2, 137
- 2BiotecVisions 2012, February, Biotechnology Journal, 2012, 7, 2Direct Link:

1549-4918/asset/olbannerleft.jpg?v=1&s=699114e871887e6b838f6a1c657fe256cfe127a6)
1549-4918/asset/olbannerright.gif?v=1&s=603f8f2ab5cd9d4f783c231915608956af51aeea)
